Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy

Anti-Nuclear Antibody (ANA) by IFA - End Point Titer

Also referred as
ANA Screening
Autoimmune
For men & women
Earliest reports in
48 hours
Contains
1 test
Test price:
₹1349
₹2400
44% off
Get it at ₹1214 with coupon
Apply coupon 1MGNEWG during checkout
arrow
discount_stamp
More offers available
Know more about this test
<font color='#864291'>Know more about this test</font>

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test helps to identify antinuclear antibodies (ANA) in the blood. These antibodies often attack your body's own tissues specifically targeting each cell's nucleus. This test helps diagnose autoimmune disorders such as lupus, rheumatoid arthritis, scleroderma, and Sjogren’s syndrome.

Samples required
Blood
Find out
Why is this test booked?
Preparations
No special preparation is required.
Sample Collection
Who will collect your samples?
Conducted by
know_more_icon
Tata 1mg Labs
chevron
most trusted lab
Accredited labs
Highly skilled Phlebos
Verified reports
Who will collect your samples?
Tata 1mg certified phlebotomists
View phlebo details

Understanding Anti-Nuclear Antibody (ANA) by IFA - End Point Titer

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test helps to detect the antibodies that specifically target components within the cell nucleus. The nucleus of the cell houses the genetic material and is central to cellular function, making antibodies against it particularly significant. This test is instrumental in identifying various autoimmune disorders, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Scleroderma, etc. 

While an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test can't confirm a specific diagnosis, it serves to rule out certain diseases. A positive result prompts further testing for specific antinuclear antibodies, some of which may be associated with particular diseases. Most individuals may have a minor percentage of ANA in their blood but having too much of it can be a sign of an autoimmune disease. 

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test conducted through the Immunofluorescence Assay (IFA) method, is one of the most sensitive screening tests for detecting ANAs. In this method, fluorescent dyes are used to detect antibodies. It provides information about the part of the cell nucleus which is being targeted by the autoantibodies Although known for its sensitivity, it is a complex method.  

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is typically suggested when a doctor suspects an autoimmune disorder due to symptoms such as joint pain, fatigue, skin rashes, light sensitivity, or inflammation. Also, it may be advised if there are risk factors such as aging, obesity, and a family history of autoimmune diseases.

Generally, no special preparations are needed for this test. However, it's advised to inform your doctor about any medications or supplements that you are taking, as certain medications may affect the test results. Additionally, telling a detailed medical history and discussing symptoms can help the doctor correlate the clinical and laboratory findings. 

The test results may vary depending on various factors like age, medical history, and certain risk factors among others. Abnormal test results require an expert interpretation; therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results. The insights from this test help the doctor tailor an appropriate treatment plan.

See more

What does Anti-Nuclear Antibody (ANA) by IFA - End Point Titer measure?

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test checks for antinuclear antibodies (ANA) in your blood. These antibodies, different from typical ones that fight off invaders in the body, can attach to structures inside the body’s own cell nuclei. If ANAs are present in the blood, it may suggest that your immune system is overly sensitive, causing inflammation against your own tissues and possibly indicating autoimmune diseases. 

Did you find information useful ?
yesYES (5)
noNO (3)

Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test price for other cities

Price inMumbaiRs. 979
Price inBangaloreRs. 1169
Price inNew DelhiRs. 1600
Price inPuneRs. 1099
Price inKolkataRs. 1399
How does home sample collection work?
Easy online booking
Easy online booking
Search for tests and packages, book your preferred time slot and enter your address for seamless at-home lab tests.
Live tracking of phlebotomist
Live tracking of phlebotomist
Track our trained phlebotomist's real time location for seamless sample collection.
Safe Sample Collection
Safe Sample Collection
Our phlebotomists follow strict safety protocols to collect samples safely at home and on time.
Sample received at lab
Sample received at lab
Samples are transported securely to our accredited labs with world-class machines for testing by qualified experts.
Quick, Doctor-Verified Reports
Quick, Doctor-Verified Reports
Get doctor-approved reports via email and WhatsApp, with options for doctor follow-ups and AI insights.

FAQs related to Anti-Nuclear Antibody (ANA) by IFA - End Point Titer

An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is a blood test that detects antibodies targeting the cell nucleus. It helps diagnose autoimmune diseases where the immune system mistakenly attacks the body's own cells.
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test is done to identify autoimmune disorders, especially when individuals exhibit symptoms like joint pain, fatigue, or skin rashes. It aids in early detection and guides appropriate treatment.
A blood sample is taken from a vein, usually in the arm. The sample is then analyzed in a laboratory to measure the presence and concentration of antinuclear antibodies.
The frequency of ANA testing depends on individual health conditions and recommendations by your doctor.
No, there is no risk associated with an Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test. However, some individuals may feel a slight sting when a needle is pricked and experience some bleeding that is normal and usually not bothersome. Rarely, some individuals may also experience slight swelling or bruising at the site of the needle prick. Applying ice 3-4 times a day for about a week may help reduce swelling and bruising. If it does not get better, consult your doctor.
Abnormal results may suggest an autoimmune response, indicating conditions like lupus or rheumatoid arthritis. However, abnormal results alone are not diagnostic and require further evaluation by a doctor.
An Anti-Nuclear Antibody (ANA) by IFA - End Point Titer test results can be affected by numerous factors including certain medications like isoniazid, hydralazine, viral infection, etc.
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation of the joints, leading to pain, swelling, and potential joint damage.
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease where the immune system attacks various organs and tissues, causing inflammation and a range of symptoms such as joint pain, skin rashes, and fatigue.
Yes. Tata 1 mg Labs offers a safe and hygienic sample collection facility from the comfort of your home.
The additional tests include the Extractable Nuclear Antigen (ENA) Panel Test; Anti-dsDNA Antibody Test; Anti-Centromere Antibody Test; Anti-Histone Antibody Test; and Anti-Smooth Muscle Antibody Test.
References
  1. Antinuclear Antibody [Internet]. Rochester, NY: University of Rochester Medical Center; [Accessed 22 Dec. 2023]. Available from:
  2. Rheumatoid Factor - an overview [Internet]. ScienceDirect; [Accessed 22 Dec. 2023]. Available from:
  3. Overview of Systemic Lupus Erythematosus (Lupus) [Internet]. NIH; Oct. 2022. [Accessed 22 Dec. 2023]. Available from:
  4. Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol. 2009 Jan 2;4:1. [Accessed 22 Dec. 2023]. Available from:
  5. Nosal RS, Superville SS, Amraei R, et al. Biochemistry, Antinuclear Antibodies (ANA) [Updated 2022 Dec 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
  6. Tešija Kuna A, Đerek L, Drvar V, Kozmar A, Gugo K. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Med (Zagreb). 2022 Jun 15;31(2):020502. [Accessed 22 Dec. 2023]. Available from:
  7. Grygiel-Górniak B, Rogacka N, Puszczewicz M. Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications. Reumatologia. 2018;56(4):243-248. [Accessed 22 Dec. 2023]. Available from:
  8. Li QZ, Karp DR, Quan J, Branch VK, Zhou J, Lian Y, Chong BF, Wakeland EK, Olsen NJ. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther. 2011 Mar 2;13(2):R38. [Accessed 22 Dec. 2023]. Available from:
  9. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011 Oct;6(4):330-6. PMID: 22879850; PMCID: PMC3391953. [Accessed 22 Dec. 2023]. Available from:
Contains 1 test
Report delivery
Samples required
Preparations
Why is this test booked?
Coupon details
Available Offers